Lung Cancer

Treating lung cancer is more precise than ever, thanks to biomarker testing, which gives clinicians a better understanding of individual’s tumors.

“I didn’t think that we were involved in great change, but then change became the name of the game.” — Loretta Ford

A colleague nominates Jody Ruth Steinhardt for the Lung Cancer Heroes® award for her commitment to changing the world for patients with lung cancer.

Patients with non-small cell lung cancer had rapid uptake of immunotherapy-containing regimens, but a shorter overall survival than patients in clinical trials.

A patient's husband writes about the persistence and passion of her oncologist, Dr. Bruno Fang, in helping her through treatment for stage 4 lung cancer.

"In the three years since her diagnosis, Lisa has become a champion for those with lung cancer, raising money for research and advocating for policies to find new treatments and cures."

View the full CURE Educated Patient Lung Cancer Summit on demand.

View the full CURE Educated Patient Lung Cancer Summit on demand.

View the full CURE Educated Patient Lung Cancer Summit on demand.

An oncologist writes about the valuable contributions of another oncologist in the field.

"Dr. Ramirez is passionate about lung cancer and his research," writes Kristen Gurba in a submission for the CURE® Lung Cancer Heroes® Award.

Lung cancer can happen to anyone, regardless of their smoking history. Two advocates discussed the need to end the stigma around the disease.

Ashley is a tremendous asset to the lung cancer community — she lives and breathes hope into her patients and providers day in and day out.

"He strengthens you with the scientific knowledge he provides, with his courage as a role model and with his fighting spirit.”

A patient writes about the impact Dr. Aaron Mansfield had on her during treatment.

From a 6-year-old cancer survivor visiting all 50 states to give wagons to pediatric patients to Kathy Griffin taking an honest look at cancer and opioid addiction, here’s what’s happening in the cancer space this week.

Patients who quit smoking after receiving a diagnosis of non-small cell lung cancer may have an almost two-year survival benefit than those who continued to smoke.

The 60-year-old comedian is optimistic about her prognosis.

"Although there is no shortage of problems to be solved across the health landscape, Marty made his bio debut by tackling one of the biggest addressable markets in oncology: lung cancer."

Articles containing misinformation on social media sites like Facebook and Twitter were more likely to be shared and liked than those with accurate information.

An oncologist writes about a local cancer care leader who developed an impressive multidisciplinary cancer team.

Join CURE® for the Educated Patient® Webinar: Individualized Treatment for Small Cell Lung Cancer on Thursday, August 26.

Online resources available to patients with lung or thyroid cancer who are considering participation in a clinical trial after undergoing comprehensive genomic profiling.

The pros and cons of conducting pathology assessments for comprehensive biomarker tests in central laboratories versus local laboratories.

"Hildy’s creative energy in founding and nurturing Upstage Lung Cancer has made many more people aware of the disease," one man writes.

A patient with small cell lung cancer nominates writes about the woman who connected her to others with the same diagnosis.

Patients with heart failure may have an increased incidence of cancer, which may be a result of similar risk factors including obesity and diabetes.

A cancer survivor writes about the oncologist who helped him conquer the fears and anxieties of cancer treatments.

The FDA’s recent approval of Rybrevant marks the first targeted therapy for a certain group of patients with non-small cell lung cancer, according to an expert at NYU Langone Health’s Perlmutter Cancer Center.

Katie Brown, senior vice president of survivorship and support for LUNGevity Foundation, wrote about a program for patients to gain knowledge from survivors.